Body mass index and response to neoadjuvant chemotherapy in breast cancer patients

被引：0

作者：

Litton, J. K. ^{[1
]}

Gonzalez, A. M. ^{[1
]}

Warneke, C. L. ^{[1
]}

Kau, S. ^{[1
]}

Buzdar, A. U. ^{[1
]}

Bondy, M. ^{[1
]}

Mahabir, S. ^{[1
]}

Hortobagyi, G. N. ^{[1
]}

Brewster, A. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

531

引用

页数：1

共 50 条

[21] Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy [J].

Takada, Koji ;

Kashiwagi, Shinichiro ;

Asano, Yuka ;

Goto, Wataru ;

Ishihara, Sae ;

Morisaki, Tamami ;

Shibutani, Masatsune ;

Tanaka, Hiroaki ;

Hirakawa, Kosei ;

Ohira, Masaichi .

BMC CANCER, 2021, 21 (01)

[22] Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy [J].

Koji Takada ;

Shinichiro Kashiwagi ;

Yuka Asano ;

Wataru Goto ;

Sae Ishihara ;

Tamami Morisaki ;

Masatsune Shibutani ;

Hiroaki Tanaka ;

Kosei Hirakawa ;

Masaichi Ohira .

BMC Cancer, 21

[23] The Impact of Body Mass Index on the Prognostic Power of Circulating Tumor Cells and Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer [J].

Fayanju, Oluwadamilola ;

Hall, Carolyn ;

Bauldry, Jessica ;

Karhade, Mandar ;

Valad, Lily ;

Kuerer, Henry ;

DeSnyder, Sarah ;

Barcenas, Carlos ;

Lucci, Anthony .

ANNALS OF SURGICAL ONCOLOGY, 2016, 23 :71-72

[24] Body mass index (BMI) is a predictor for response to neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger. [J].

Eralp, Y ;

Smith, TL ;

Kau, SW ;

Valero, V ;

Buzdar, A ;

Hortobagyi, GN ;

Arun, B .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :27S-27S

[25] High body mass index (BMI) and worse response to neoadjuvant chemotherapy (NACT) by breast cancer phenotype: Own data and external validation on German breast group (GBG) patients [J].

Vanoppen, M. ;

Brouckaert, O. ;

Laenen, A. ;

Fontanella, C. ;

Wildiers, H. ;

Paridaens, R. ;

Leunen, K. ;

Amant, F. ;

Berteloot, P. ;

Smeets, A. ;

Loibl, S. ;

Floris, G. ;

Christiaens, M-R ;

Vergote, I. ;

Neven, P. .

CANCER RESEARCH, 2013, 73

[26] IMPACT OF BODY MASS INDEX (BMI) ON DISEASE FREE SURVIVAL AND LIKELIHOOD OF PATHOLOGIC COMPLETE RESPONSE IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER TREATED WITH NEOADJUVANT CHEMOTHERAPY [J].

Armengol-Alonso, A. ;

Arance, A. ;

Campayo, M. ;

Gonzalez-Farre, X. ;

Garcia-Herrera, A. ;

Fernandez, P. L. ;

Caparros, X. ;

Alonso, I. ;

Farrus, B. ;

Munoz, M. .

ANNALS OF ONCOLOGY, 2012, 23 :135-135

[27] Optical Mammography in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: Individual Clinical Response Index [J].

Anderson, Pamela G. ;

Kalli, Sirishma ;

Sassaroli, Angelo ;

Krishnamurthy, Nishanth ;

Makim, Shital S. ;

Graham, Roger A. ;

Fantini, Sergio .

ACADEMIC RADIOLOGY, 2017, 24 (10) :1240-1255

[28] A role for immune response in the response to neoadjuvant chemotherapy for breast cancer patients [J].

Kim, R. ;

Kawai, A. ;

Wakisaka, M. ;

Funaoka, Y. ;

Yasuda, N. ;

Ohtani, S. ;

Ito, M. ;

Arihiro, K. .

BREAST, 2017, 32 :S79-S79

[29] RADIONUCLIDE EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS [J].

Solodyannikova, O. .

RADIOTHERAPY AND ONCOLOGY, 2010, 94 :S30-S30

[30] Radionuclide evaluation of response to neoadjuvant chemotherapy in breast cancer patients [J].

Solodyannikova, O. ;

Voit, N. ;

Dzhuzha, D. ;

Sukach, G. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 :S305-S305

← 1 2 3 4 5 →